Lv7
5000 积分 2021-09-17 加入
Trends in the drug target landscape for autoimmune diseases
1个月前
已完结
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders需要补充材料Supplementary Appendix和Protocol
1个月前
已完结
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders
1个月前
已完结
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders
1个月前
已完结
Impact of injection sites on clinical pharmacokinetics of subcutaneously administered peptides and proteins
2个月前
已完结
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
3个月前
已完结
rAAV8 encapsidated HMR-001/z enables high efficiency hepatic transduction and restores hemostasis in hemophilic mice
4个月前
已关闭
Subcutaneous blinatumomab in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: post-hoc safety and activity analysis from a multicentre, single-arm, phase 1/2 trial
6个月前
已完结
Subcutaneous blinatumomab in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: post-hoc safety and activity analysis from a multicentre, single-arm, phase 1/2 trial
6个月前
已完结
T-cell engagers in rheumatology
6个月前
已关闭
皖公网安备34019202002308
